Update on antiviral therapy for genital herpes infection.

Title

Update on antiviral therapy for genital herpes infection.

Creator

Geers T A; Isada C M

Publisher

Cleveland Clinic journal of medicine

Date

2000
2000-08

Description

For the primary infection of genital herpes, antiviral therapy with acyclovir is the gold standard. For recurrences, there are two options: antiviral treatment of each outbreak as it arises, or suppression of outbreaks with daily oral therapy. Patients tend to prefer the latter because it can decrease the number and severity of outbreaks, but it increases asymptomatic viral shedding and, therefore, the risk of unwittingly transmitting herpes simplex virus to uninfected sexual partners.

Subject

Female; Humans; Male; Infant; Pregnancy; Recurrence; 2-Aminopurine/analogs & derivatives/therapeutic use; Acyclovir/analogs & derivatives/therapeutic use; Antiviral Agents/*therapeutic use; Famciclovir; Valacyclovir; Valine/analogs & derivatives/therapeutic use; Pregnancy Complications; Herpes Genitalis/diagnosis/*drug therapy; Herpes Simplex/transmission; Virus Shedding; Newborn; Infectious Disease Transmission; Infectious/drug therapy; Vertical

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

567–573

Issue

8

Volume

67

Citation

Geers T A; Isada C M, “Update on antiviral therapy for genital herpes infection.,” NEOMED Bibliography Database, accessed April 17, 2021, https://neomed.omeka.net/items/show/5195.

Social Bookmarking